1.- Hume D.M., Merrill BF, Thorn G W: Experiences with renal homotransplantation in the human: report of nine cases. J. Clin. Invest. 34:327-382, 1955

2.- Heemann U W, Schmidt A., Azuma H., Tilneu N.L: The role of leucoyte adhesion molecules inacute transplant rejection. Curr Opin Nephrol Hypertens 3(4): 459-464, 1994.

3.- Hall BM, Dorsch SE. Cell mediating allograft rejection. Inmunol. Rev. 77: 31-59, 1984.

4.- Milford EL., Hancock W, Carpenter Ch B. Immunopathogenetic mechanisms of allograft rejection in Renal Pthology vol II. Craig Tisher. B B Brenner edit. J.B. Lippincott Co. Philadelphia 1994. Pag. 1581-1590

5.- Forbes RDC, Guttmann RD. Pathogenetic studies of cardiac allograft rejection using inbred rat models. Immunol. Rev. 77:5-29,1984.

6.- Mihatsch M.J., Thiel G., Ryffel B. Histopathology of Cyclosporine nephrotoxicity. Transplant Proc. 20:759-771, 1988.

7.- Alexopoulos E., Leontsini M., Diniilidies M. Et al. Differentiation between renal allograft rejection and Cyclosporine toxicity: A clinicopathological study.  Am. J. Kidney Dis. 18: 108-115, 1991.

8.- Koning O.H.J., Ploeg R.J., Hajo Van Bockel, et al. Risk factors for delayed graft function in cadaveric Kidney transplantatation. Transplantation 63:1620-1628, 1997.

9.- Canafax D.M. Torres A., Fryd D.S. et al. The effects of delayed graft function on recipients of cadever renal allografts. Transplantation 41:177-181, 1986.

10. Cameron S. Glomerulonephritis in renal tarnsplants. Transplantation 34: 237-245,1982.

11. Cameron S. Recurrent primary disease and de novo nephritis following renal transplantation. Pediatr. Nephrol. 5:412-1991.

12. Scrooggs M.W., Wolfe J.A., Bollinger R.R. and Sanfilippo F. Causes of death in renal transplant recipients. Arch. Pathol. Lab. Med. 111:983-987, 1987.

13. Lautenschlager I., Salmela K, Häyry P. Does CMV infection affect the outcome of renal allografts.?. Transplant Proc. 24, 281-282, 1992.

14. Peterson Ph. K., Balfour H.H., Marker S.C. et al. Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine 59: 283-300, 1980.

15. Cameron J., Rigby R.J., Van Deth A.G. Petrie J.B. Severe tubulo-interstitial disease in a renal allograft fue to cytomegalovirus infection. Clinical Nephrol. 18:321-325, 1982.

16. London N.J., Farmery S.M., Will E.J., Davison A.M., Ludge J.P.A. Risk of neoplasia in renal transplant patients. Lancet 346:403-406, 1995.

17. Cosio F., Pelletier R.P., Falkenhain M E et al. Impact of acute rejection and early allograft function on renal allograft survival. Transplant 63:1611-1615, 1997

18. Tesi R.J. Henry M.L. Elkhammas E.A., Ferguson. Predictors of long-term primary cadaveric renal transplant survival. Clin. Transplant. 7:345,1993.

19. Alonso A. Tresancos, C., Riera C. Micofenolato Mofetil prevention of acute rejection in the renal transplantation. Abstract. I Congress International of Immunodepression. Orlando. Florida D.C. 1997.

20. Goeken N.E., Outcome of renal transplantation following a positive crossmatch with historical sera. Transplant Proc. 17:2443-2445, 1985.

21. Croker B.P. Ramos E.L. Pathology of the renal allograft en Tisher C.C., Brenner B.M., Renal Pathology with clinical and functional correlation. Ed 2 Vol.II Philadelphia, 1994. Lippicott, pag. 1591-1640.

22. Cosimi A.B., Colvin R.B., Burton R.C. et al. Use of monoclopnal antibodies to T. Cell subsets for immunologic monitoring and treatment in recipients of renal allografts. New Engl. J. Med. 305:308-314,1981.

23. Kooijmans-Coutinho MF , Herman S.J., Schrama E., et al. Interstitital rejection, vascular rejection, and diffuse thrombosis of renal allograft.Transplantation 61:1338-1344-1996.

24. Kin Solez, Axelsen R.A., Benediktsson H. Et al. International Standardization of criteria for histologic diagnosis of renal allograft rejection: The Banff working cvlassification of kidney transplant pathology Kidney Intern. 44:411-422, 1993.

25. Castelao A.M., Griño J.M. Seron D., Andres E., et al. Pathological differential diagnostics of proteinuria and late failure after renal transplantation. Transplantation Proc. 24: 110-112,1992

26. Fernandez Rivera, C., Oliver García J., Alonso Hernandez et al. Proteinuria en trasplante renal: incidencia, etiología, factores de riesgo y pronóstico. Resumen de la XXIV Reunion de la Sociedad Española de Nefrología. Nefrología XIII. Suplem. 1. Pag. 83. 1993.

27. Myers B.D. Cyclosporine nephrotoxicity. Kidney Int. 30: 964-974, 1988

28. Isoniemi H., Taskinen E., Häyry P. Histological chronic allograft damege index accurately predicts chronic renal allograft rejection. Transplantation 58: 1195-1198, 1994.

29. Solez K, Benediktsson HJ., CavalloT et al. Report of the thir Banff Conference on allograft pathology (July 20-24 y 1995) on classification and lesion scoring in renal allograft pathology. Transplant. Proc. 28:441-444, 1996.

30. Troppmann C., Gillingham K.J., Benedetti E. Et al. Delayed graft function, acute rejection, and out come after cadaver renal transplantation. A multivariate analysis. Transplantation 59:962-968, 1995.

31. Habib R., Antingnac C., Hinglais N. Et al. Glomerular lesions in the transplanted kidney in children Am. J. Kidney Dis 3: 198-207,1987.

32. Fogo A., Hakim R., Sugiura M. Et al. Severe endothelial injury in a renal transplant patient receiving Cyclosporine. Transplantation 49: 1190-1192, 1990.

33. Greenberg A, Holley J., McCauley. The spectrum of Cyclosporine nephrotoxicity. Am. J. Nephrol. 10: 296-302,1990.

34. Shanley P.F., The pathology of Chronic renal ischemia. Seminars Nephrol. 16:21-32,1996.